Maternal-Foetal HLA-DQB1 Incompatibility Is Associated With Pregnancy-Induced Hypertensive Disorders in a Genetically...

Area of Science:

• Reproductive immunology
• Human genetics
• Obstetrics

Background:

• Semi-allogenic fetal trophoblasts express specific HLA profiles crucial for placentation and maternal leukocyte contact.
• Maternal immunomodulation paradoxically requires fetal antigen recognition, involving specific HLA molecules.
• Pre-eclampsia, a severe hypertensive complication, has been linked to antigenic similarity, suggesting HLA mismatches may be involved in immune regulation for uncomplicated pregnancies.

Purpose of the Study:

• To investigate preferential selection for HLA compatibility in a genetically isolated population.
• To determine the relationship between HLA compatibility and hypertensive complications during pregnancy.

Main Methods:

• Nested case-control study in a genetically isolated Dutch population (125 uncomplicated, 50 hypertensive pregnancies).
• Genotyping for maternal and fetal HLA-A, -B, -C, -DRB1, -DQA1, -DQB1 and maternal KIR.
• Comparison of observed maternal-fetal HLA (mis)matches against expected values and prediction of mismatched CD4+ T cell epitopes using PIRCHE-II algorithm.

Main Results:

• No significant differences in maternal-fetal HLA (mis)matches were observed in uncomplicated pregnancies compared to expectations.
• Pregnancies with hypertensive complications exhibited significantly higher observed HLA-DQB1 mismatches, correlating with PIRCHE-II scores.
• No significant differences were found in KIR/HLA-C frequencies between groups.

Conclusions:

• Maternal-fetal HLA-DQB1 mismatch appears to play a role in the etiology of hypertensive pregnancy complications within this population.
• While interpretation is limited by sample size and grouping of hypertensive disorders, HLA-DQB1 mismatch is a potential factor in pregnancy-induced hypertension and pre-eclampsia.